The definition of IgM multiple myeloma

American Journal of Hematology

Volumn 86, Issue 8, 2011, Pages 718-719

  Schuster, Steven R ^a   Rajkumar, S Vincent ^b   Dispenzieri, Angela ^b   Morice, William ^b   Aspitia, Alvaro Moreno ^b   Ansell, Stephen ^b   Kyle, Robert ^b   Mikhael, Joseph ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; IMMUNOGLOBULIN M;

ANTIGEN EXPRESSION; BONE LESION; CHROMOSOME 14Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 4; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HUMAN; IGM MULTIPLE MYELOMA; IMMUNOPHENOTYPING; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79960346540     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22080     Document Type: Letter

References (5)

1. Schuster SR, Rajkumar SV, Dispenzieri A, et al. IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia. Am J Hematol 2010; 85: 853-855.
2. Donovan KA, Lacy MQ, Gertz M, et al. IL-1b expression in IgM monoclonal gammopathy and its relationship to multiple myeloma. Leukemia 2002; 16: 382-385.
3. Rajkumar SV, Kyle RA, Buadi FK. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc 2010; 85: 945-948.
4. Feyler S, O'Connor SJM, Rawstron AC, et al. IgM myeloma: A rare entity characterized by a CD20-CD56-CD117-immunophenotype and t(11;14). Br J Haematol 2007; 140: 547-551.
5. Avet-Loiseau H, Garand R, Lode L, et al. 14q32 translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia. Sem Oncol 2003; 30: 153-155.